Anaphylaxis and Mast Cell Disease: What Is the Risk?

被引:45
作者
Akin, Cem [1 ]
机构
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02445 USA
关键词
Anaphylaxis; Mastocytosis; Mast cells; C-kit; HYMENOPTERA VENOM ALLERGY; SYSTEMIC MASTOCYTOSIS; C-KIT; IDIOPATHIC ANAPHYLAXIS; BONE-MARROW; ACTIVATING MUTATION; SERUM TRYPTASE; DISORDERS; CLASSIFICATION; IMMUNOTHERAPY;
D O I
10.1007/s11882-009-0080-8
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Mastocytosis is a proliferative disorder of the hematopoietic mast cell progenitor that results from expansion of a clone carrying the D816V c-kit mutation. Based on the dramatic increase in incidence of anaphylaxis in patients with mastocytosis, recent studies analyzed the presence of clonal mast cell markers, including D816V c-kit mutation, in patients with recurrent IgE- and non-IgE-mediated anaphylaxis. These studies demonstrated the presence of an aberrant mast cell clone in a significant proportion of patients with unexplained anaphylaxis, or anaphylaxis due to hymenoptera venom. Clonal mast cell disease should be suspected in particular in patients presenting with profound cardiovascular manifestations such as hypotension and syncope in the absence of urticaria.
引用
收藏
页码:34 / 38
页数:5
相关论文
共 50 条
  • [1] Anaphylaxis and Mast Cell Disease: What Is the Risk?
    Cem Akin
    Current Allergy and Asthma Reports, 2010, 10 : 34 - 38
  • [2] Mast Cell Activation Syndromes Presenting as Anaphylaxis
    Akin, Cem
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2015, 35 (02) : 277 - +
  • [3] Idiopathic Anaphylaxis: A Form of Mast Cell Activation Syndrome
    Giannetti, Matthew P.
    Akin, Cem
    Castells, Mariana
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (04) : 1196 - 1201
  • [4] Clonal mast cell disorders and hereditary α-tryptasemia as risk factors for anaphylaxis
    Kacar, Mark
    Rijavec, Matija
    Selb, Julij
    Korosec, Peter
    CLINICAL AND EXPERIMENTAL ALLERGY, 2023, 53 (04) : 392 - 404
  • [5] Insights in Anaphylaxis and Clonal Mast Cell Disorders
    Gonzalez-de-Olano, David
    Alvarez-Twose, Ivan
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [6] Anaphylaxis and Mast Cell Disorders
    Gulen, Theo
    Akin, Cem
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2022, 42 (01) : 45 - 63
  • [7] Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels
    Bonadonna, Patrizia
    Perbellini, Omar
    Passalacqua, Giovanni
    Caruso, Beatrice
    Colarossi, Sabrina
    Dal Fior, Daniela
    Castellani, Luca
    Bonetto, Chiara
    Frattini, Francesco
    Dama, Annarita
    Martinelli, Giovanni
    Chilosi, Marco
    Senna, Gianenrico
    Pizzolo, Giovanni
    Zanotti, Roberta
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (03) : 680 - 686
  • [8] Mast Cell Activation Disorders
    Giannetti, Arianna
    Filice, Emanuele
    Caffarelli, Carlo
    Ricci, Giampaolo
    Pession, Andrea
    MEDICINA-LITHUANIA, 2021, 57 (02): : 1 - 13
  • [9] Recent advances in our understanding of mast cell activation - or should it be mast cell mediator disorders?
    Theoharides, Theoharis C.
    Tsilioni, Irene
    Ren, Huali
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2019, 15 (06) : 639 - 656
  • [10] The presence of mast cell clonality in patients with unexplained anaphylaxis
    Gulen, T.
    Hagglund, H.
    Sander, B.
    Dahlen, B.
    Nilsson, G.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2014, 44 (09) : 1179 - 1187